• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Nectar Lifesciences Limited — Board Meeting, 30-05-2026: Outcome of Board Meeting

    30-05-2026 | 02:56 pm

    Nectar Lifesciences announced a full-year consolidated loss of ₹292.89 Cr. The board approved a strategic pivot to real estate after selling pharma/menthol businesses for ₹1,253.98 Cr, generating ₹163.37 Cr profit. An ₹81 Cr share buyback was also completed.

    No comments yet. Be the first to comment!

    All announcements from Nectar Lifesciences Limited